Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

$CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL$

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

AbbVie, a research-based global biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has granted a positive opinion for VENCLYXTO® in combination with rituximab for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia who have received at least one prior therapy.

21 Sep 2018

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

GlaxoSmithKline plc and Innoviva, Inc. announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion today supporting the use of Trelegy Ellipta in a broader group of patients with moderate to severe chronic obstructive pulmonary disease and that labeling, if approved, will be updated to further reflect its effect on exacerbations of COPD.

21 Sep 2018

Researchers demonstrate pre-clinical success for universal flu vaccine in new paper

Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

21 Sep 2018

Researchers use neutrons to make first direct observations of water in lipid bilayers

New 3D maps of water distribution during cellular membrane fusion are accelerating scientific understanding of cell development, which could lead to new treatments for diseases associated with cell fusion.

21 Sep 2018

Study highlights need to remain vigilant in maintaining key infection control processes

Healthcare-associated infections can be reduced by up to 55 percent by systematically implementing evidence-based infection prevention and control strategies, according to a review of 144 studies published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

21 Sep 2018

Study: Annual wellness visits improve delivery of preventive services in elderly population

new Harvey L. Neiman Health Policy Institute study assesses the effect of receiving an Annual Wellness Visit between 2011 and 2013 on the annual rate of eight preventive services recommended for the Medicare population following the AWV.

21 Sep 2018

Pfizer’s 20vPnC vaccine receives Breakthrough Therapy designation from FDA

Pfizer Inc. announced today that its 20-Valent Pneumococcal Conjugate Vaccine candidate, PF-06482077, received Breakthrough Therapy designation from the US Food and Drug Administration for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes in the vaccine in adults aged 18 years and older. Pfizer expects to start Phase 3 trials in a few months.

20 Sep 2018

Top three immune boosting recommendations to ward off freshers’ flu

Those heading to university this autumn, or returning student’s, might’ve heard of the dreaded freshers’ flu. But don’t let it fool you, it isn’t actually a form of flu.

20 Sep 2018

Emergex signs MoU with Brazil’s Fiocruz for development of viral vaccines

Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious diseases, today announces that it has signed a Memorandum of Understanding with Brazil-based Oswaldo Cruz Foundation 'Fiocruz' for the development of viral vaccines.

20 Sep 2018

Vax-Hub to influenze radical change in development and manufacturing of vaccines

Vax-Hub, a new Future Vaccine Manufacturing Research Hub, will bring together academia, industry and policy makers to affect radical change in the development and manufacturing of vaccines and improve responses to outbreaks of deadly pandemics such as Swine Flu and Ebola.

20 Sep 2018

Scientists better understand influenza virus and how it spreads

The seasonal flu is caused by different subtypes of Influenza A virus and typically leads to the death of half a million people each year.

20 Sep 2018

Health care companies' data could enable more accurate flu season forecasts

In an era when for-profit companies collect a wealth of data about us, new research from The University of Texas at Austin shows that data collected by health care companies could -- if made available to researchers and public health agencies -- enable more accurate forecasts of when the next flu season will peak, how long it will last and how many people will get sick.

20 Sep 2018

Zika virus could become a weapon against brain cancer

Zika virus infection is a dreaded one that can lead to severe brain damage in the unborn babies of mothers who get it.

20 Sep 2018

Study: Infants using popular anti-reflux medicines are not at increased risk of lung infections

New University of Otago research shows infants using popular anti-reflux medicines like omeprazole are not at increased risk of pneumonia or other lower respiratory tract infections, contrary to findings from other international studies.

19 Sep 2018

Study finds why some human genes are more popular with biomedical researchers

Historical bias is a key reason why biomedical researchers continue to study the same 10 percent of all human genes while ignoring many genes known to play roles in disease, according to a study publishing September 18 in the open access journal PLOS Biology, led by Thomas Stoeger and Luís Amaral of Northwestern University, and colleagues. This bias is bolstered by research funding mechanisms and social forces.

19 Sep 2018

AmpliPhi receives positive feedback from FDA for its AB-PA01 product targeting P.aeruginosa infections

AmpliPhi Biosciences Corporation, a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that the company has received positive feedback, via written response, from the U.S. Food and Drug Administration regarding its development plans for AB-PA01, without the need for a Type B Pre-IND meeting.

19 Sep 2018

Experts to present research on prevention, management of dysphagia at international conference

Over 800 delegates from 46 countries will attend the 8th annual European Society for Swallowing Disorders Congress taking place in Dublin next week to hear about new developments in swallowing disorder research.

19 Sep 2018

Study finds higher readmission rates in for-profit hospitals

Patients who receive care in a for-profit hospital are more likely to be readmitted than those who receive care in nonprofit or public hospitals, according to a new study published by University of Illinois at Chicago researchers.

19 Sep 2018

NUS researchers develop new device for quick and accurate screening of diseases

A multidisciplinary team of researchers at the National University of Singapore has developed a portable, easy-to-use device for quick and accurate screening of diseases.

18 Sep 2018

Investigational nasal influenza vaccine tested in children and teens

An early-stage clinical trial testing the safety and immune-stimulating ability of an experimental nasal influenza vaccine in healthy 9- to 17-year-old children and teens has begun enrolling participants at a Vaccine and Treatment Evaluation Unit site at Saint Louis University, St. Louis, Missouri.

17 Sep 2018

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

Researchers demonstrate pre-clinical success for universal flu vaccine in new paper

Researchers use neutrons to make first direct observations of water in lipid bilayers

Study highlights need to remain vigilant in maintaining key infection control processes

Study: Annual wellness visits improve delivery of preventive services in elderly population

Pfizer’s 20vPnC vaccine receives Breakthrough Therapy designation from FDA

Top three immune boosting recommendations to ward off freshers’ flu

Emergex signs MoU with Brazil’s Fiocruz for development of viral vaccines

Vax-Hub to influenze radical change in development and manufacturing of vaccines

Scientists better understand influenza virus and how it spreads

Health care companies' data could enable more accurate flu season forecasts

Zika virus could become a weapon against brain cancer

Study: Infants using popular anti-reflux medicines are not at increased risk of lung infections

Study finds why some human genes are more popular with biomedical researchers

AmpliPhi receives positive feedback from FDA for its AB-PA01 product targeting P.aeruginosa infections

Experts to present research on prevention, management of dysphagia at international conference

Study finds higher readmission rates in for-profit hospitals

NUS researchers develop new device for quick and accurate screening of diseases

Investigational nasal influenza vaccine tested in children and teens

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in